For instance, serum prostate-specific antigen (PSA) is the most reliable and widely used clinical biomarker for diagnosing prostate cancer, and successful therapy for prostate cancer depends heavily on the detection of biomarkers [24,25]. Here, KLK3 is linked to prostate carcinoma.